Skip to content


  • Poster presentation
  • Open Access

Pharmacodynamic analysis and concentration mapping for efficient delivery through the FUS-induced BBB opening in non-human primates in vivo

  • 1,
  • 1,
  • 1,
  • 1 and
  • 1
Journal of Therapeutic Ultrasound20153(Suppl 1):P33

Published: 30 June 2015


  • Pharmacodynamic Analysis
  • Dynamic Contrast Enhance
  • Gadolinium Concentration
  • Variable Flip Angle
  • Drug Delivery Efficiency


FUS in conjunction with systemically administered microbubbles has been previously shown to open the Blood-Brain Barrier (BBB) locally, non-invasively and reversibly in non-human primates. However, a trans-BBB pharmacodynamic analysis has not been performed as of yet. The objective of this study was to perform such an analysis, i.e. permeability, relaxivity and gadolinium concentration mapping, of the NHP brain in vivo in order to further investigate the effect of FUS, and its dependence on the acoustic parameters used for safe and efficient drug-delivery as well as the gray vs. white matter occurrence.


Two brain structures, the caudate and the putamen, were targeted in three rhesus macaques using FUS (center frequency: 500 kHz; pulse length: 5,000 cycles; PRF: 2 Hz; sonication duration: 120 s; peak negative pressure: 300-500 kPa) immediately after the IV administration of monodisperse bubbles (diameter: 4-5 μm, 2.5*108#/kg). Following sonication, the macaques were placed in a 3T MR scanner (Philips Medical System, Andover, MA, USA). Five pre-contrast 3D Spoiled Gradient Echo (SPGR) images (TR/TE: 10/4ms, FA: 5o-35o, NEX: 3, matrix: 256x256, resolution: 1x1x1 mm3) were acquired and used for variable flip angle *VFA) based T1 relaxivity mapping. Subsequently, Dynamic Contrast Enhanced (DCE) imaging was performed, with the acquisition of 90 dynamic T1-weighted 3D repetitions (TR/TE: 4.2/1.7 ms; matrix: 256x256, resolution 1x1x2 mm3). The data of the DCE were processed off-line using a customized Matlab-based algorithm and fitted to the General Kinetic Model using the Patlak method to generate permeability maps.

Quantitative permeability changes (Ktrans) and the volume of BBB opening after excluding the vasculature were obtained based on the T1 relaxivity maps. The areas of gray and white matter where BBB opening was induced were also determined, since they have distinctive characteristic relaxivity times. Gadolinium concentration [Gd] maps were then calculated from the T1, pre map before MR-CA injection and the T1, post maps after MR-CA injection using the following equation: [Gd] =1/r_Gd (1/T_(1, post) -1/T_(1, pre)). Vasculature and CSF were excluded from the opening volume based on their T1 relaxivity which was measured to be above 1400 ms.

Results and conclusions

The volume of opening increased from 92±10 mm3 to 262±34 mm3 with a pressure increase from 300 kPa to 500 kPa increased. The average permeability was increased from 1.0531 ± 0.0761*10-4 s-1 to 1.863 ± 0.132*10-4 s-1 with the same pressure increase. When targeting the putamen, an average of 95% of the BBB opening regions was contained in the grey matter (T1 relaxivity range: 1001-1400 ms), while when targeting the caudate 87% of the BBB-opened regions were in the gray matter and the rest in the white (T1 relaxivity range: 600-1000 ms). No edema or hemorrhage was detected in any of the cases studied. FUS-induced drug delivery efficiency was measured in vivo for the first time and increased with the acoustic pressure used; the amount of gadolinium in the opened BBB area increased from 10 μg to 20 μg on average when pressure increased from 300 to 600 kPa. This type of analysis as performed in this study may prove critical for clinical applications.
Figure 1
Figure 1

T1 map overlaid with permeability map in a coronal view


Acknowledgements (Funding)

The authors wish to acknolwedge Matthew Downs and Carlos Sierra Sanchez for their input and help. Funding: National Institutes of Health (R01 EB009041 & R01AG038961), Wallas H. Coulter Foundation, Focused Ultrasound Foundation.

Authors’ Affiliations

Columbia University, New York, United States


© Samiotaki et al; licensee BioMed Central Ltd. 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.